GN44028 |
An inhibitor of HIF-1α transcriptional activity; reduces HIF-1&alpha… |
5 mg |
37289-5 |
More Info
|
25G-NBOMe (hydrochloride) |
A derivative of the designer drug 2C-G; intended for research and forensic… |
1 mg |
14065-1 |
More Info
|
25G-NBOMe (hydrochloride) |
A derivative of the designer drug 2C-G; intended for research and forensic… |
10 mg |
14065-10 |
More Info
|
25G-NBOMe (hydrochloride) |
A derivative of the designer drug 2C-G; intended for research and forensic… |
5 mg |
14065-5 |
More Info
|
GNE-0877 |
A selective, brain-penetrable LRRK2 inhibitor (Ki = 0.7 nM); inhibits LRRK… |
1 mg |
16251-1 |
More Info
|
GNE-0877 |
A selective, brain-penetrable LRRK2 inhibitor (Ki = 0.7 nM); inhibits LRRK… |
5 mg |
16251-5 |
More Info
|
GNE-0877 |
A selective, brain-penetrable LRRK2 inhibitor (Ki = 0.7 nM); inhibits LRRK… |
500 µg |
16251-500 |
More Info
|
GNE-2861 |
A group 2 PAK inhibitor (IC50s = 7.5, 126, and 36 nM for PAK4, -5, and -6,… |
5 mg |
29458-5 |
More Info
|
GNE-317 |
A dual PI3Kα and mTOR inhibitor (apparent Kis = 2 and 9 nM, respecti… |
10 mg |
27671-10 |
More Info
|
GNE-317 |
A dual PI3Kα and mTOR inhibitor (apparent Kis = 2 and 9 nM, respecti… |
25 mg |
27671-25 |
More Info
|
GNE-317 |
A dual PI3Kα and mTOR inhibitor (apparent Kis = 2 and 9 nM, respecti… |
5 mg |
27671-5 |
More Info
|
GNE-317 |
A dual PI3Kα and mTOR inhibitor (apparent Kis = 2 and 9 nM, respecti… |
50 mg |
27671-50 |
More Info
|
GNE-3511 |
A selective and highly potent inhibitor of DLK; also inhibits phosphorylat… |
1 mg |
19174-1 |
More Info
|
GNE-3511 |
A selective and highly potent inhibitor of DLK; also inhibits phosphorylat… |
10 mg |
19174-10 |
More Info
|
GNE-3511 |
A selective and highly potent inhibitor of DLK; also inhibits phosphorylat… |
25 mg |
19174-25 |
More Info
|
GNE-3511 |
A selective and highly potent inhibitor of DLK; also inhibits phosphorylat… |
5 mg |
19174-5 |
More Info
|
GNE-477 |
A dual PI3K (IC50 = 4 nM for PI3Kα) and mTOR inhibitor (apparent Ki… |
10 mg |
27977-10 |
More Info
|
GNE-477 |
A dual PI3K (IC50 = 4 nM for PI3Kα) and mTOR inhibitor (apparent Ki… |
25 mg |
27977-25 |
More Info
|
GNE-477 |
A dual PI3K (IC50 = 4 nM for PI3Kα) and mTOR inhibitor (apparent Ki… |
5 mg |
27977-5 |
More Info
|
GNE-477 |
A dual PI3K (IC50 = 4 nM for PI3Kα) and mTOR inhibitor (apparent Ki… |
50 mg |
27977-50 |
More Info
|
GNE-493 |
A dual inhibitor of PI3K and mTOR (IC50s = 3.4, 12, 16, and 16 nM for PI3K… |
1 mg |
29224-1 |
More Info
|
GNE-493 |
A dual inhibitor of PI3K and mTOR (IC50s = 3.4, 12, 16, and 16 nM for PI3K… |
10 mg |
29224-10 |
More Info
|
GNE-493 |
A dual inhibitor of PI3K and mTOR (IC50s = 3.4, 12, 16, and 16 nM for PI3K… |
25 mg |
29224-25 |
More Info
|
GNE-493 |
A dual inhibitor of PI3K and mTOR (IC50s = 3.4, 12, 16, and 16 nM for PI3K… |
5 mg |
29224-5 |
More Info
|
GNE-495 |
An orally bioavailable, potent, and selective MAP4K4 inhibitor (IC50 = 3.7… |
1 mg |
21808-1 |
More Info
|